ALS/FTD: Evolution, Aging, and Cellular Metabolic Exhaustion
Amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD) are neurodegenerations with evolutionary underpinnings, expansive clinical presentations, and multiple genetic risk factors involving a complex network of pathways. This perspective considers the complex cellular pathology of aging...
Main Authors: | Robert David Henderson, Kasper Planeta Kepp, Andrew Eisen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.890203/full |
Similar Items
-
Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells
by: Wenting Guo, et al.
Published: (2017-12-01) -
Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis
by: Siobhan E. Kirk, et al.
Published: (2019-03-01) -
Neural circuit and synaptic dysfunctions in ALS-FTD pathology
by: Santiago Mora, et al.
Published: (2023-07-01) -
Overexpression of UBQLN1 reduces neuropathology in the P497S UBQLN2 mouse model of ALS/FTD
by: Shaoteng Wang, et al.
Published: (2020-10-01) -
The era of cryptic exons: implications for ALS-FTD
by: Puja R. Mehta, et al.
Published: (2023-03-01)